MEDI
Harbor Health Care ETF
MEDI seeks long-term capital growth by actively managing a narrow portfolio of stocks engaged in the health care sector globally.
Global
EQUITY
Active
MANAGEMENT STYLE
$ 41.6 M
ASSETS UNDER MGMT
80 bp
EXPENSES
Fund Basics
| Inception date | Nov 17, 2022 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| ELI LILLY & CO | 22.2 % |
| ASCENDIS PHARMA AS | 15.4 % |
| ARGENX SE ADR | 4.3 % |
| RHYTHM PHARMACEUTICALS, INC. | 3.8 % |
| NATERA INC | 2.9 % |
| INSMED INC | 2.9 % |
| ABBVIE INC | 2.6 % |
| GUARDANT HEALTH, INC. | 2.5 % |
| GILEAD SCIENCES INC | 2.4 % |
| VAXCYTE, INC. | 2.3 % |
Constituent Breakdown
| Number of holdings | 45 |
| Herfindahl-Hirschman Index | 856 |
| Wgt avg mkt cap (mns) | $278,573 |
| Large cap (>$10bn) | 62.5% |
| Mid cap ($2-10bn) | 19.4% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 81.9% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 76.4 % |
 |
NETHERLANDS | 4.3 % |
 |
COSTA RICA | 0.6 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 4.1% | 14.6% | 8.1% | 14.0% | -- | -- | -- | 14.0% |
| Dividend Yield | 0.0% | 0.0% | 0.3% | 0.9% | -- | -- | -- | 0.7% |
| Total Returns | 4.1% | 14.6% | 8.4% | 15.0% | -- | -- | -- | 14.7% | Ann. Volatility | 21.4% | 20.2% | 21.4% | 19.7% | -- | -- | -- | 18.7% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.52 | 11% |
| MSCI EAFE | 0.52 | 16% |
| MSCI Emg Mkts | 0.15 | 4% |
Liquidity Measures
| Avg. volume (000) | 4 |
| ADV traded (mns) | $0 |
| Turnover | 0.3% |
| Avg. Bid/Ask (% of price) | 0.19% |
Technical Indicators
| 30d moving avg. (EMA) | $33.32 |
| Relative strength (RSI) | 57 |
| MACD/Signal | 0.32/0.24 |
| Bollinger Bands (Upper/Lower) | $34.67/$31.95 |
| Short interest (% of AUM) | 0.5% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. MEDI |
Expenses vs. MEDI |
ALTAR Score™ vs. MEDI |
|---|---|---|---|---|
| FHLC | Fidelity MSCI Health Care Index ETF | 30.8% | -72 bp | +5.6% |
| VHT | Vanguard Health Care ETF | 30.8% | -71 bp | +5.5% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 30.5% | -5 bp | +2.7% |
| XLV | Health Care Select Sector SPDR | 30.4% | -72 bp | +6.8% |
| PPH | VanEck Pharmaceutical ETF | 30.3% | -44 bp | +7.9% |
| IYH | iShares U.S. Healthcare ETF | 30.3% | -40 bp | +6.1% |
| HRTS | Tema Heart & Health ETF | 29.5% | -5 bp | +3.2% |
| GFLW | VictoryShares Free Cash Flow Growth ETF | 26.5% | -41 bp | +5.1% |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 26.3% | -67 bp | +6.8% |
| IHE | iShares U.S. Pharmaceuticals ETF | 25.7% | -40 bp | +6.2% |
Risk and Returns: MEDI vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 10/20/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
-0.6%
ALTAR SCORE™
3rd
PERCENTILE
AVOID
ETFRC RATING
There are 735 funds in the Global Equity category with an average
ALTAR Score™ of 4.6% and a standard deviation
of 2.7%. MEDI's ALTAR Score™ is approximately -1.9 standard
deviations above the category average. This places MEDI in the 3rd percentile
among funds in the category.
Sell-Side Consensus
$40.97
PRICE TARGET
+25.8%
UPSIDE